Phibro Animal Health Corp (NASDAQ:PAHC)
| 19.95 Delayed Data As of Dec 03 |  -0.22 / -1.09%Today’s Change | 17.70 Today|||52-Week Range 31.00 | +2.73% Year-to-Date |
Latest PAHC News | Press Releases
| Phibro (PAHC) Down 12.3% Since Last Earnings Report: Can It Rebound? Dec 02 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 20.17 |
| Today’s open | 19.96 |
| Day’s range | 19.81 - 20.23 |
| Volume | 1,023 |
| Average volume (3 months) | 100,017 |
| Market cap | $885.4M |
Data as of 3:59pm ET, 12/03/2021
Growth & Valuation
| Earnings growth (last year) | +62.01% |
| Earnings growth (this year) | +0.52% |
| Earnings growth (next 5 years) | -10.57% |
| Revenue growth (last year) | +4.12% |
| P/E ratio | 16.6 |
| Price/Sales | 1.40 |
| Price/Book | 3.71 |
Competitors
| ---- | ||
| KDNYChinook Therapeutics... | -0.58 | -3.68% |
| KNSAKiniksa Pharmaceutic... | -0.04 | -0.34% |
| SNDXSyndax Pharmaceutica... | +0.02 | +0.12% |
Data as of 4:00pm ET, 12/03/2021
Financials
| Next reporting date | February 7, 2022 |
| EPS forecast (this quarter) | $0.33 |
| Annual revenue (last year) | $833.4M |
| Annual profit (last year) | $54.4M |
| Net profit margin | 6.53% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Teaneck, New Jersey |
Forecasts
